IFM Investors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-38,041
| Closed | -$2.05M | – | 617 |
|
|
2025
Q3 | $2.05M | Hold |
38,041
| – | – | 0.02% | 506 |
|
|
2025
Q2 | $2.09M | Buy |
38,041
+1,587
| +4% | +$93.5K | 0.02% | 497 |
|
|
2025
Q1 | $2.58M | Hold |
36,454
| – | – | 0.03% | 466 |
|
|
2024
Q4 | $2.4M | Sell |
36,454
-1,874
| -5% | -$126K | 0.02% | 491 |
|
|
2024
Q3 | $2.69M | Hold |
38,328
| – | – | 0.03% | 487 |
|
|
2024
Q2 | $3.16M | Hold |
38,328
| – | – | 0.03% | 443 |
|
|
2024
Q1 | $3.35M | Buy |
38,328
+158
| +0.4% | +$14.1K | 0.04% | 428 |
|
|
2023
Q4 | $3.68M | Sell |
38,170
-1,072
| -3% | -$94.8K | 0.04% | 372 |
|
|
2023
Q3 | $3.47M | Buy |
39,242
+2,969
| +8% | +$264K | 0.05% | 377 |
|
|
2023
Q2 | $3.14M | Sell |
36,273
-539
| -1% | -$50.7K | 0.04% | 406 |
|
|
2023
Q1 | $3.58M | Buy |
36,812
+1,488
| +4% | +$154K | 0.05% | 347 |
|
|
2022
Q4 | $3.66M | Hold |
35,324
| – | – | 0.06% | 328 |
|
|
2022
Q3 | $2.99M | Buy |
35,324
+1,612
| +5% | +$144K | 0.05% | 349 |
|
|
2022
Q2 | $2.79M | Buy |
33,712
+4,695
| +16% | +$374K | 0.05% | 367 |
|
|
2022
Q1 | $2.24M | Buy |
29,017
+4,348
| +18% | +$364K | 0.03% | 467 |
|
|
2021
Q4 | $2.18M | Sell |
24,669
-470
| -2% | -$38.8K | 0.04% | 428 |
|
|
2021
Q3 | $1.94M | Hold |
25,139
| – | – | 0.04% | 435 |
|
|
2021
Q2 | $2.1M | Buy |
25,139
+4,721
| +23% | +$374K | 0.04% | 437 |
|
|
2021
Q1 | $1.54M | Buy |
20,418
+3,018
| +17% | +$247K | 0.04% | 440 |
|
|
2020
Q4 | $1.53M | Buy |
17,400
+2,960
| +20% | +$235K | 0.05% | 376 |
|
|
2020
Q3 | $1.1M | Buy |
14,440
+1,127
| +8% | +$114K | 0.05% | 374 |
|
|
2020
Q2 | $1.64M | Sell |
13,313
-5,455
| -29% | -$542K | 0.08% | 238 |
|
|
2020
Q1 | $1.55M | Sell |
18,768
-800
| -4% | -$68.9K | 0.07% | 275 |
|
|
2019
Q4 | $1.65M | Sell |
19,568
-965
| -5% | -$72.9K | 0.06% | 336 |
|
|
2019
Q3 | $1.38M | Buy |
20,533
+8,763
| +74% | +$675K | 0.05% | 371 |
|
|
2019
Q2 | $1.01M | Hold |
11,770
| – | – | 0.06% | 351 |
|
|
2019
Q1 | $1.05M | Buy |
11,770
+1,545
| +15% | +$143K | 0.07% | 309 |
|
|
2018
Q4 | $871K | Buy |
10,225
+1,177
| +13% | +$112K | 0.07% | 286 |
|
|
2018
Q3 | $877K | Buy |
9,048
+1,327
| +17% | +$132K | 0.07% | 305 |
|
|
2018
Q2 | $727K | Buy |
7,721
+2,440
| +46% | +$214K | 0.07% | 306 |
|
|
2018
Q1 | $428K | Buy |
5,281
+428
| +9% | +$36.7K | 0.06% | 355 |
|
|
2017
Q4 | $433K | Buy |
4,853
+41
| +0.9% | +$3.56K | 0.07% | 337 |
|
|
2017
Q3 | $448K | Buy |
4,812
+124
| +3% | +$11K | 0.08% | 301 |
|
|
2017
Q2 | $426K | Buy |
4,688
+1,327
| +39% | +$121K | 0.08% | 308 |
|
|
2017
Q1 | $295K | Buy |
+3,361
| New | +$299K | 0.07% | 317 |
|
Other funds holding BMRN
